HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Hydroxychloroquine Sulfate

WITHDRAWN · PHASE3 · Coronavirus Infections, SARS-CoV 2, SARS (Severe Acute Respiratory Syndrome), Pulmonary Disease

This study was canceled before enrollment due to a decision by the Sponsor

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.